Abstract:Background Maternal cardiovascular profile of patients developing late fetal growth restriction is yet to be well characterized, although a subclinical impairment of maternal hemodynamics and cardiac function may be present before pregnancy, becoming evident because of the hemodynamic alterations of pregnancy. Objectives Our objective was to investigate if maternal hemodynamics and the cardiovascular profile might be different in the preclinical stages (22-24 weeks gestation) of early and late fetal growth restriction in normotensive patients. Study design This was a prospective echocardiographic study of 1152 normotensive nulliparous pregnant women at 22-24 weeks' gestation. The echocardiographic evaluation included morphological parameters (left ventricular mass index and relative wall thickness, left atrial volume index) as well as systolic and diastolic maternal left ventricular function (ejection fraction, left ventricular LV global longitudinal strain, E/A, and E/e'). Patients were followed until the end of pregnancy to note the development of normotensive early or late fetal growth restriction. Results 1049 patients had no complications, 73 were classified as late fetal growth restriction and 30 as early fetal growth restriction. Left Ventricular Morphology Left ventricular end-diastolic diameter was greater in uneventful pregnancies (4.84±0.28 cm) vs late (4.67±0.26 cm) and vs early fetal growth restriction (4.55±0.26 cm) (p<0.001), whereas left ventricular end-systolic diameter was smaller in uneventful pregnancies (2.66±0.39 cm) vs late (2.83±0.40 cm) and early fetal growth restriction (2.82±0.38 cm) (p<0.001). Relative wall thickness was slightly higher in early (0.34±0.05) and late fetal growth restriction (0.35±0.04) vs uneventful pregnancies (0.32±0.05) (p<0.05). Systolic Left Ventricular Function At 22-24 weeks' cardiac output was higher in uneventful pregnancies (6.58±1.07 L/min) vs late (5.40±0.97 L/min) and vs early fetal growth restriction (4.76±1.05 L/min) (p<0.001), with the lowest values in the early onset group. Left ventricular global longitudinal strain was lower in AGA (-21.6±2.0%), and progressively higher in late (-20.1±2.2%) and early fetal growth restriction (-18.5±2.3%) (p<0.001). Diastolic Left Ventricular Function E/e' ratio showed intermediate values in the late fetal growth restriction (7.90±2.73) vs AGA (7.24±2.43) and vs early fetal growth restriction (10.76±3.25) (p<0.001). Total Peripheral Vascular Resistance Total Peripheral Vascular Resistance was also intermediate in the late fetal growth restriction (1300±199 dyne·s·cm -5 ) vs AGA (993±175 dyne·s·cm -5 ) and vs early fetal growth restriction (1488±255 dyne·s·cm -5 ) (p<0.001). Conclusions Early and late fetal growth restriction share similar maternal hemodynamic and cardiovascular profiles with a different degree of expression. These features are already present at 22-24 weeks gestation and are characterized by a hypodynamic state. The degree of these cardiovascular changes may influence the timing of the manifestation of the disease: a hypovolemic, high resistance, low cardiac output state might be associated to early onset fetal growth restriction, whereas a milder hypovolemic state seems to favor a development of the disease in the final stages of pregnancy.

OP05.02: Cardiac remodelling in late‐onset fetal growth restriction: any relation between the phenotype of cardiac remodelling and speckle tracking fetal echocardiography?

Preliminary Results Analysis for Left Ventricular Systolic Function in Normal Fetuses by Automated Cardiac Motion Quantitation

EP09.47: Speckle tracking assessment of the fetal cardiac function in early labour: pathophysiology and association with adverse outcome

EP08.23: Speckle tracking echocardiography in fetuses at risk for late‐onset FGR: can we discriminate SGA and FGR and predict the progression from SGA to FGR?

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

EP09.93: Cardiac remodelling and exercise tolerance in small for gestational age: a follow‐up cohort study from preadolescence into adolescence

EP09.45: Decreased biventricular longitudinal function in tetralogy of Fallot fetuses by speckle tracking echocardiography

Cardiovascular Adaptation in Fetal Growth Restriction: A Longitudinal Study From Fetuses at Term to the First Year of Life

EP09.83: Clinical value of the two‐dimensional speckle tracking technique for evaluating cardiac size remodelling in small‐for‐gestational age fetuses

Comparative assessment of myocardial function between late premature newborns and term neonates using the 2D speckle tracking method

EP09.46: Biventricular remodelling in tetralogy of Fallot starts from fetal life

OC09.03: Speckle tracking echocardiography in fetal pulmonary valve stenosis improves the detection of neonatal valvuloplasty

Subclinical cardiac impairments in fetuses conceived through assisted reproductive technology by speckle tracking echocardiography

Persistence of Cardiac Remodeling in Preadolescents With Fetal Growth Restriction

OP01.09: Ultrasound predictors of abnormal severe neonatal outcomes in late fetal growth restriction

Review of speckle tracking analysis to measure the size, shape, and contractility of the fetal heart in fetuses with congenital heart defects

OP01.08: Value of adding angiogenic factors to ultrasound Doppler criteria in the definition of fetal growth restriction

Fetal myocardial deformation measured with two‐dimensional speckle‐tracking echocardiography: longitudinal prospective cohort study of 124 healthy fetuses

Maternal cardiovascular profile is altered in the pre-clinical phase of normotensive early and late fetal growth restriction

Fetal and neonatal echocardiographic analysis of biomechanical alterations for the systemic right ventricle heart

EP09.11: Cord blood cardiovascular biomarker profile in Fallot fetuses and its correlation with the severity of right ventricle outflow tract obstruction